Vincent A, Newsom-Davis J
Clin Exp Immunol. 1985 Jun;60(3):631-6.
Twenty-five myasthenia gravis (MG) patients whose anti-acetylcholine receptor (anti-AChR) titres against denervated human leg AChR fell in the range of less than 0.1-2.0 nM were tested against AChR preparations from normal human leg muscle, and from human extra-ocular muscle, and the results compared with those of sera with titres greater than 2.0 nM. Seven sera failed to react appreciably with any of the AChR. Many of the remaining 18 low titre sera reacted better with normal leg and ocular AChR than with denervated AChR. In contrast, sera from patients with high anti-AChR titres generally reacted better with denervated, AChR, and as a group this was significantly different from the low titre patients. Sera reacting better with ocular AChR are not restricted to patients with purely ocular symptoms. The results indicate a subgroup of myasthenia gravis patients who have low titres, tend to be male and have relatively mild disease. The aetiology of the autoimmune disorder in this subgroup may differ from that in other MG patients.
对25例抗去神经支配人腿部乙酰胆碱受体(anti-AChR)滴度在0.1 - 2.0 nM以下的重症肌无力(MG)患者,用来自正常人腿部肌肉和人眼外肌的AChR制剂进行检测,并将结果与滴度大于2.0 nM的血清的结果进行比较。7份血清与任何一种AChR均无明显反应。其余18份低滴度血清中的许多与正常腿部和眼部AChR的反应比与去神经支配的AChR更好。相比之下,抗AChR高滴度患者的血清通常与去神经支配的AChR反应更好,并且作为一个群体,这与低滴度患者有显著差异。与眼部AChR反应更好的血清并不局限于仅有眼部症状的患者。结果表明存在一个重症肌无力患者亚组,他们滴度低,多为男性,疾病相对较轻。该亚组自身免疫性疾病的病因可能与其他MG患者不同。